Combinations containing TAF and cobicistat linked to physical depression symptoms in women with HIV
San Francisco shows that long-acting cabotegravir and rilpivirine may be feasible for people without viral suppression
Switching to injectable cabotegravir and rilpivirine rarely affects body weight
Sharing anti-HIV medication is common in rural Uganda
Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment
Good news for women and PrEP: quarterly dosing may work
Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment
Doxycycline PEP after sex appears ineffective for cisgender women
No marked increase in gonorrhoea resistance in doxyPEP study
